Increased use of opioids by pregnant women is resulting in an increase of babies born with neonatal abstinence syndrome (NAS). While the incidence of NAS varies by regions of the state, all hospitals in Florida are seeing an increase in pregnant women using opioids and their opioid dependent babies.
FHA and the Florida Perinatal Quality Collaborative (FPQC) is offering this educational opportunity for those hospitals that are not participating in the new NAS initiative. FPQC, which focuses on improving maternal and infant health and health care, has developed a comprehensive toolkit, useful online resources and other evidence-based practices/materials for treating infants exhibiting post-natal signs of withdrawal due to chronic in utero exposure to opioids.
The purpose of this webinar to review the tools and resources that are available for all Florida hospitals that provide care to women and infants. The event will also include recommendations on forming a multi-disciplinary team, strategies for caregiver engagement, guideline developments, screening and identification, managing care and requirements for safe discharge plans for NAS infants. FPQC will make other NAS webinars available on other important topics such as Non-Pharmacological Management, Plans of Safe Care, Finnegan Scoring and more.
Who should attend: Maternal/Child Health Directors, NICU Directors, Chief Nursing Officers, Chief Medical Officers, Education Specialists, Case Managers/Discharge Planners and Quality Improvement Teams.